Dashboard
Manage Tickers

BKX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citi-outperforms-analyst-expectations-with-12-revenue-growth-confirms-20-billion-buyback-plan
Citi Outperforms Analyst Expectations With...
01/16/2025 19:11:54

Citi enjoyed a solid quarter, with a revenue beat driven by net interest income. The board approved a new $20 billion share buy...

keycorp-gets-analyst-upgrade-due-to-superior-balance-sheet-net-interest-income
KeyCorp Gets Analyst Upgrade Due To Superi...
12/20/2023 21:49:33

Shares of KeyCorp (NYSE: KEY) have climbed steadily over the past month.

bill-ackman-warns-no-regional-bank-can-survive-current-crisis-running-out-of-time-to-fix-the-problem
Bill Ackman Warns No Regional Bank Can Sur...
05/04/2023 06:09:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION